Predicted Trait | |
Reported Trait | Lung cancer |
Mapped Trait(s) | lung carcinoma (EFO_0001071) |
Score Construction | |
PGS Name | PRS18_LC |
Development Method | |
Name | Genome-wide significant variants |
Parameters | P < 5e-8 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 18 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000226 |
Citation (link to publication) | Xie J et al. Sleep (2021) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 85,716 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004748 Europe PMC: 2860473 |
85,716 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002521 | PSS001139| European Ancestry| 382,598 individuals |
PGP000226 | Xie J et al. Sleep (2021) |
Reported Trait: Incident lung cancer | HR: 1.2 [1.15, 1.26] | — | — | Sex, education (college or uni- versity degree/vocational qualification, other qualification), smoking status (never, former, current), pack-years, alcohol in- take (nondrinker, <1, 1-10, 10-20, ≥20 g/day), physical activity (Metabolic Equivalent Task hours per week, MET-h/week), and body mass index (BMI, kg/m2) | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001139 | Cases were individuals with lung cancer. Lung cancer cases were ascertained through record linkage to the National Health Service central registries and death registries. The endpoint was identified using ICD-10 (International Classification of Diseases, 10th revision) codes (C33 and C34). | — | [
|
— | European | — | UKB | — |